This report explored the possibility that maternal hyperglycemia during pregnancy might produce a competition between glucose ( G ) and ascorbic acid (AA) and reduce the transfer of AA to the fetus using an in vivo single-pass placental perfusion technique in the guinea pig. Levels of G in maternal plasma increased from 104 Comparison of the AA in placental tissue from fetuses of dams infused with either solution demonstrates that significantly less AA was present after AA + G infusion (P < 0.005). Additionally, when AA + G was infused a significant decrease in AA transferred across the placenta was found ( P < 0.001) as maternal plasma G increased beyond 200 mg/dl. The data suggest that in the guinea pig glucose may compete with ascorbic acid transfer across the placenta and that maternal hyperglycemia may reduce the bioavailability of AA to the fetus.
Ascorbic acid is present in all tissues of the body (3, 9) . Among those tissues that have been studied, the uptake of this compound displays saturation kinetics (4,7, 10, ll,20,24,26,28-33) . Because most of these tissues also accumulate ascorbic acid against a concentration gradient, transport is believed to be carrier mediated and energy dependent. Recent reports indicate that glucose inhibits the uptake of ascorbic acid by red blood cells and heart endothelial cells in vitro (17, 34) and suggest that due to structural similarities, glucose and ascorbic acid compete for carrier sites on the cell surface. If this occurs in vivo, the hyperglycemia that accompanies overt diabetes could reduce the tissue uptake of ascorbic acid.
Previous reports from this laboratory indicate that ascorbic acid is transported across the placenta by a carrier-mediated mechanism in man and the guinea pig (20, 33) . Because both species require ascorbic acid as a vitamin (3) the fetus relies totally on the placental transfer of ascorbic acid to supply its developmental and metabolic needs. Therefore, maternal hyperglycemia during pregnancy might produce a competition between glucose and ascorbic acid for carrier sites on the placental membrane and reduce the transfer of ascorbic acid to the fetus. This report was designed to explore this possibility using an in vivo single-pass placental perfusion technique in the guinea pig.
MATERIALS .AND METHODS
Outbred, Hartley strain guinea pigs (Camm Research Inst., Wayne, NJ) were ob~ained near term (68-72 days) of their second gestation. Upon arrival, the animals were caged individually in a room with 50% humidity, constant temperature (22°C) and a 12 h light-dark cycle. A standard guinea pig diet and water were provided a d libitum. At the time of study the gestational age of the animals, extrapolated from fetal weights (12, 13) , was estimated to be between 60 and 67 days.
The technique to measure ascorbic acid (AA) transfer in an in situ preparation has been described in detail elsewhere (20) . ~r i e f l~, cannulae were inserted into the maternal jugular vein and carotid artery and a venous blood sample was obtained to establish base-line AA and glucose (G) levels. The uterus was exposed through a midline abdominal incision and a fetus, whose placenta was positioned to allow easy access to all vessels, was chosen. The umbilical vein and an umbilical artery were cannulated. The fetus was removed and the placenta perfused (1 ml/min) with calf serum and saline (l:l, v/v) via the umbilical artery. Perfusion fluid was warmed to 38OC before entering the placenta by passage through a coil submerged in the saline bath in which the lower half of the guinea pig was immersed. Blood levels of AA and G then were increased by infusion (4.3 ml/h) into the maternal jugular vein. This infusion fluid contained either AA alone or AA and G dissolved in lactated Ringer's solution. Both solutions were prepared immediately before use with L-ascorbic acid and Dglucose (36) . Perfusate leaving the umbilical vein was not recirculated but collected at 3-min intervals yielding 3-ml samples. After an initial 10 min of placental perfusion, maternal infusion began into the jugular vein. Maternal blood samples were taken before the placental perfusion period and at 15-min intervals throughout the infusion period via the carotid artery. Similarly, blood samples were obtained whenever possible from the umbilical vein of fetuses left in utero before and after maternal infusion. At the conclusion of each experiment (90 min), placentas were retained for analysis. Maternal blood pressure and heart rate were monitored throughout each experiment by a transducer (Statham, Hato Rey, PR) attached to tubing from the carotid artery and connected to a polygraph (Grass Instrument Co., Quincy, MA).
All samples of plasma, placental homogenate and perfusate either remained on ice for prompt assay or were deproteinized and stored (-20°C) for assay within 3 days (20) . Measurements of AA were performed using the Bessey et al. (1) modification of the 2,4 dinitrophenylhydrazine method. Assays of AA and blood G from dams infused with AA and G were performed immediately upon completion of an experiment. Glucose levels in plasma and perfusate were determined by a glucose oxidase method (Gluco-Stat, General Diagnostics, Morris Plains, NJ).
Differences in means between values obtained after AA infusion with and without glucose were tested using the Student's t test. The relationship between maternal and fetal plasma levels before and after AA infusion was analyzed using simple regression techniques. To determine whether there was a difference in the relationship between maternal and fetal levels in the group exposed to AA and G and the group exposed to AA alone, an F test was used. Multiple regression analyses were used to estimate the relationship between the amount of AA crossing the placenta per min per g of placenta and maternal plasma AA concentration holding maternal plasma G levels constant. Analysis of covariance was used to determine if a statistically significant difference occurred between the G and the non-G experiments (8, 14) .
RESULTS
At the beginning of surgery, blood pressure for all animals was within the normal range for guinea pigs (19) , systolic 80 f 7 mmHg and diastolic 53 +. 5 mmHg (% +_ S.E.). Upon opening the abdomen the systolic and diastolic blood pressure dropped to 49 2 3 mmHg and 26 f 4 mmHg, respectively. This lowered blood pressure remained stable throughout the remainder of each experiment. Heart rate was stable and normal throughout each study, 218 f 8 (Z + S.E.) beats per min (19) . Significant differences in these parameters were not found among the 14 animals infused with AA alone and the four dams infused with the combination AA and G solution (AA + G).
The perfused placentas and the fetuses from the perfused placentas did not differ significantly in weight from the nonperfused placentas and fetuses among the dams infused with either AA or AA + G. Each dam was infused with a single solution of AA or AA + G . Preinfusion levels of AA in maternal plasma were 0.29 + 0.02 (S.E.) mg/dl and maternal infusion of either AA or AA + G produced significant increases in maternal plasma AA levels ( P < 0.025, Fig. 1) . Similarly, the levels of G in maternal plasma increased from 104 _+ 4 (S.E.) mg/dl before AA + G infusion to 370 + 19 (S.E.) mg/dl at the end of each study ( P < 0.001, Fig. 2 ).
Plasma G levels among five dams infused with only AA were 93 +_ 6 (S.E.) mg/dl after the infusion period. Before the maternal infusion, AA levels in fetal plasma, 0.46 + 0.03 (S.E.) mg/dl, were significantly higher than maternal plasma values ( P < 0.001).
Maternal infusion of either AA or AA + G significantly increased the AA concentration in 24 fetal plasma samples to 0.92 f 0.06 (S.E.) mg/dl ( P < 0.001); however, during AA + G infusion lower fetal plasma levels were observed than during maternal infusion of AA alone ( P < 0.005, Fig. 3 ). These results suggest that when maternal plasma G concentration is increased the transport of AA to the fetus is reduced.
Preinfusion levels of AA in placental tissue were 10.8 +_ 0.5 (S.E.) mg/100 g of tissue and infusion of either AA or AA + G produced significant increases in the AA content of all placentas that were examined, 39.6 + 3.3 (S.E.) mg/100 g of tissue ( P < 0.001). Further, a comparison of the AA in the placental tissue from dams infused with either AA or AA + G demonstrates that significantly less AA was present in this organ after maternal infusion of AA + G (P < 0.005, Fig. 4 ).
Because the concentration of AA in the perfusate leaving the placenta was measured and the rate of placental perfusion and the placental weight were known, it was possible to calculate the nmoles of AA that crossed the placenta per min, per g of placenta. Figure 5 shows these data plotted against maternal plasma AA concentration when either AA or AA -b G were infused. Analysis of these data revealed a significant decrease in AA transferred, expressed as nmoles of AA per min, per g of tissue when AA + G was infused (Fig. 5) . For all maternal plasma AA levels among dams infused with AA + G corresponding maternal plasma G levels were known. Accordingly, multiple regression analysis was used to estimate the relationship between maternal plasma AA and the amount of AA crossing the placenta holding maternal plasma G levels constant. This analysis determined that placental transport of AA was decreased significantly ( P < 0.001) when AA + G was administered. Finally, analysis of covariance was used to determine if a statistically significant difference in AA transport occurred between dams infused with AA and those given AA + G (Table 1) . Placental transport of AA was not affected at The relationship between maternal plasma ascorbic acid levels and placental tissue ascorbic acid concentrations before and after maternal infusion of either ascorbic acid alone (0) or ascorbic acid and glucose (0). The estimated regression equations are: preinfusion, y = 9.6 + 3.6~; after ascorbic acid infusion, y = 58.7 + 0.4~; after ascorbic acid and glucose infusion, y = 10.6 + 4.8~. All postinfusion values are significantly different from preinfusion levels (P < 0.001). Placental tissue ascorbic acid levels after ascorbic acid and glucose infusion were significantly lower than placental ascorbic acid concentrations found when only ascorbic acid was infused (P < 0.005). Each point represents a single observation.
maternal plasma glucose levels below 200 mg/dl; however, at maternal plasma glucose levels between 201-250 mg/dl significantly less AA crossed the placenta per min, per g of placenta ( P < 0.01). At maternal plasma G levels above 250 mg/dl, the significance level of this decreased AA transport increased ( P < 0.001, Table 1 ).
DISCUSSION
Previous reports from this laboratory have demonstrated that AA is transported across the placenta by a carrier-mediated mechanism in the rat, guinea pig, and man (20, 24, 33) . Present data suggest that in the guinea pig, glucose may compete with AA for the placental carrier and decrease the bioavailability of AA to the fetus. Therefore, maternal hyperglycemia during pregnancy may affect the placental transfer of AA in man.
In both the depancreatized dog (22) and the streptozotocindiabetic rat ( 3 9 , the serum level of AA is decreased relative to the nondiabetic animal whereas urinary excretion of the vitamin is increased. Lower serum AA levels have also been reported among diabetic humans ( 2, 3, 5, 27 ). Although these studies did not attempt to correlate these findings with blood G levels, they are consistent with an hypothesis that the bioavailability of AA is reduced in diabetes mellitus.
Two studies have estimated the tissue AA status of the diabetic individual by measuring the concentration of AA in leucocytes. One group of 127 diabetic subjects was found to have lower leucocyte AA levels than the nondiabetic controls ( 5 ) whereas a second group of 44 diabetic patients had leucocyte AA levels that were similar to control subjects (27) . Other studies that have examined the tissue levels of AA in diabetes indicate that platelets from diabetic humans (25) and liver tissue from alloxan-diabetic rats (23) also have lower AA content than control specimens. In addition, the present study suggests that placental tissue AA levels may be affected by maternal hyperglycemia. A comparison of the placental tissue AA levels among animals infused with either AA alone or AA + G demonstrates that significantly less AA is present in placental tissue from dams infused with AA + G.
Vitamin C exists in blood and tissues in two biologically active forms, either the reduced L-ascorbic acid (LAA), or the oxidized dehydroascorbic acid (DHA). Both forms possess 100% biologic activity (6); however, it appears that DHA is the only form of the between maternal plasma ascorbic acid a n d the nmoles o f ascorbic acid crossing t h e placenta per m i n per g placenta holding maternal plasma glucose levels constant (y = -0.27 + 0 . 6 7~ -0.08x2 -0.16 glucose). W h e n ascorbic acid a n d glucose were infused, t h e nmoles o f ascorbic acid crossing t h e placenta per g o f placenta were significantly less t h a n when ascorbic acid alone was infused (P < 0.001). vitamin that is transported by the carrier-mediated process (10, 11, 18, 20, 21) . This may explain why diabetic subjects have been reported to have higher levels of DHA in their plasma than nondiabetic individuals (2, 3, 27) . The present study indicates that an acute episode of maternal hyperglycemia (>200 mg/dl) can reduce markedly the AA that is transferred by the guinea pig placenta. These experiments have not explored the effect of chronic maternal hyperglycemia during pregnancy. Still, the possible implications of the present finding for the gestational diabetic deserve further attention particularly because many similarities have been suggested between the various angiopathies associated with diabetes mellitus and the degeneration of vascular tissue that accompanies ascorbic acid deficiency (16, 17, 33) .
